Live talk, session 10 – June 30, 2022: emotional well-being, mental health and the pituitary

July 1, 2022

Mental health and emotional wellness are essential topics for pituitary patients, their families, and friends. This on-demand session from last Thursday’s live-talk program focuses on the challenges and opportunities when considering these issues. This is a compelling discussion from the psychological and the medical point of view about the importance of putting people’s mental and emotional well-being center stage when considering the medical and psychological treatment of endocrine disorders. PWN contributor and author Linda M Rio chats with Dr. Lewis Blevis and myself about tools and resources and the need for more research and work in this critical pituitary patient care and wellness area.

Acromegaly (part 2)

June 2, 2015

In part 2 of our series on Acromegaly Dr. Blevins deals with Dopamine Agonists, a class of drugs used in the treatment of acromegaly.  Stay tuned for part 3 in the series coming up very

Acromegaly (part 1)

May 25, 2015

This is part one of an upcoming series of podcasts by Dr. Blevins on Acromegaly exclusively produced for Pituitary Word News.   From the early 90’s, where very few options existed for the treatment of Acromegaly,

Adrenal Insufficiency

May 19, 2015

Podcast – Adrenal insufficiency is the inability of the Adrenal Gland to perform its usual functions. In this exclusive podcast, Dr. Blevins explains the concept of adrenal insufficiency and shares his perspectives and approach to treatment.

Lab tests in Endocrinology

May 11, 2015

In this podcast Dr Blevins reviews some of the concepts that relate to the interpretation of lab tests results in endocrinology.  He uses T4, TSH and Igf-1 tests to illustrate some of the key points

Hormone replacement in women – Part 2

May 5, 2015

Podcast – Our series on hormone replacement for women continues in this podcast by Dr. Lewis Blevins.     Photo: “Purple flower closeup” by Arturo Mann – Own Work + Garden. Licensed under CC BY-SA 3.0 via